Paper3550239
Microalbuminuria as a predictor of clinical diabetic nephropathy.
Mogensen CE. Kidney Int, 1987. Cited by 549 papers, by iCite.
Cite this record
ConductScience Library. Microalbuminuria as a predictor of clinical diabetic nephropathy. Papers, record 3550239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3550239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Albuminuria | Major topic |
| Diabetic Nephropathies | Major topic |
| Adult | |
| Diagnosis, Differential | |
| Glomerular Filtration Rate | |
| Humans | |
| Male |
Source PubMed
Cited by97
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 549 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857346 | The effects of ursodeoxycholic acid on albuminuria in people with type 1 diabetes and diabetic kidney disease: a proof-of-concept study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42857346 | PubMed |
| 42391213 | Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes. | PLoS One | 2026 | https://conductscience.org/library/papers/42391213 | PubMed |
| 42154771 | U-shaped association between waist-to-height ratio and microalbuminuria: A cross-sectional analysis conducted within the Chinese demographic. | PLoS One | 2026 | https://conductscience.org/library/papers/42154771 | PubMed |
| 40993757 | Social risk profiles and diabetic kidney disease: prevalence and mortality in US adults. | BMC Public Health | 2025 | https://conductscience.org/library/papers/40993757 | PubMed |
| 40486272 | Potentilla discolor Bunge Ameliorates Streptozotocin-Induced Diabetic Nephropathy in Mice by Modulating GAS5 and miR-21 Expression. | Int J Endocrinol | 2025 | https://conductscience.org/library/papers/40486272 | PubMed |
| 39265079 | Glucagon receptor activation contributes to the development of kidney injury. | Am J Physiol Renal Physiol | 2024 | https://conductscience.org/library/papers/39265079 | PubMed |
| 39011603 | Astaxanthin attenuates diabetic kidney injury through upregulation of autophagy in podocytes and pathological crosstalk with mesangial cells. | Ren Fail | 2024 | https://conductscience.org/library/papers/39011603 | PubMed |
| 38459493 | Association of domain-specific physical activity with albuminuria among prediabetes and diabetes: a large cross-sectional study. | J Transl Med | 2024 | https://conductscience.org/library/papers/38459493 | PubMed |
| 38255295 | Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes. | Biomedicines | 2024 | https://conductscience.org/library/papers/38255295 | PubMed |
| 37781459 | Lost in translation: assessing the nomenclature change for diabetic kidney disease in Japan. | Diabetol Int | 2023 | https://conductscience.org/library/papers/37781459 | PubMed |
| 37469989 | Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37469989 | PubMed |
| 36552716 | Effect of Metabolic Adaptation by Voluntary Running Wheel Activity and Aldosterone Inhibition on Renal Function in Female Spontaneously Hypertensive Rats. | Cells | 2022 | https://conductscience.org/library/papers/36552716 | PubMed |
| 36071841 | Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36071841 | PubMed |
| 32549781 | Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. | J Med Biochem | 2020 | https://conductscience.org/library/papers/32549781 | PubMed |
| 31966947 | Prevalence and Risk Factors for Microalbuminuria in Children with Sickle Cell Disease at King Abdulaziz University Hospital: A Retrospective Cross-sectional Study. | Cureus | 2020 | https://conductscience.org/library/papers/31966947 | PubMed |
| 31043336 | Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes. | J Clin Lipidol | 2019 | https://conductscience.org/library/papers/31043336 | PubMed |
| 30997374 | Stability of urinary albumin and creatinine after 12 months storage at -20 °C and -80 °C. | Pract Lab Med | 2019 | https://conductscience.org/library/papers/30997374 | PubMed |
| 29371774 | A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive Subjects. | Indian J Clin Biochem | 2018 | https://conductscience.org/library/papers/29371774 | PubMed |
| 29104709 | Paper-based assays for urine analysis. | Biomicrofluidics | 2017 | https://conductscience.org/library/papers/29104709 | PubMed |
| 29082239 | Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/29082239 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3550239
GET https://conductscience.org/api/papers/v1/3550239/cited_by?page=2